Skip to main content
. 2018 May 11;8(5):42. doi: 10.1038/s41408-018-0075-6

Fig. 5.

Fig. 5

a Increased serum Semaphorin 4D (Sema4D) levels correlated with higher ISS stage in multiple myeloma patients (p < 0.001). b Serum Semaphorin 4D (Sema4D) levels in patients with osteolyses vs. those without bone disease in plain radiographs (p = 0.07)